alexa Hepatitis B | Norway | PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Read more

Recommended Journals

Relevant Topics

Hepatitis B

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Hepatitis B

    Hepatitis B: Hepatitis B is a potentially life-threatening liver infection caused by the hepatitis B virus. It is a major global health problem. It can cause chronic infection and puts people at high risk of death from cirrhosis and liver cancer.Symptoms: Most people do not experience any symptoms during the acute infection phase. However, some people have acute illness with symptoms that last several weeks, including yellowing of the skin and eyes (jaundice), dark urine, extreme fatigue, nausea, vomiting and abdominal pain

  • Hepatitis B

    Causes: The virus also can pass from a mother to her newborn child at birth or soon afterward. Most adults with hepatitis B get better, but a small percentage can't shake the disease and become carriers, which means they can spread it to others even when their own symptoms disappear.Diagnosis: Laboratory diagnosis of hepatitis B infection focuses on the detection of the hepatitis B surface antigen HBsAg. Acute HBV infection is characterized by the presence of HBsAg and immunoglobulin M (IgM) antibody to the core antigen, HBcAg. The presence of HBeAg indicates that the blood and body fluids of the infected individual are highly contagious.

  • Hepatitis B

    Treatment: care is aimed at maintaining comfort and adequate nutritional balance, including replacement of fluids lost from vomiting and diarrhoea. Statistics: The incidence of hepatitis B declined 80%, falling from 10.7 per 100,000 (25,916 cases reported) to 2.1 per 100,000 (6,212 cases reported) in all age groups, and the largest proportional decrease among 0-15 years (-95%) and 15-24 years (-87%) [12]. In 2009, 3,371 new cases were reported to Centre for Diseases Control and Prevention (CDC). Prevalence of HBsAg-positive individuals – chronic infection was generally low (0.33% in 1976-1980, 0.42% in 1988-1994 and 0.30% in 2005-2006). 

Expert PPTs

Speaker PPTs

 

High Impact List of Articles

Conference Proceedings